JOHNSON & Johnson has
finalised its takeover of Micrus
Endovascular.
As part of the J&J family, Micrus,
a developer and manufacturer of
minimally invasive devices for
hemorrhagic and ischemic stroke,
will operate under Codman
Neurovascular (a division of J&J’s
DePuy family of companies).
Both Micrus and Codman
produce complementary
technologies for treating cerebral
aneurysms, and will work together
to develop products for
hemorrhagic stroke and ischemic
stroke.
According to Codman &
Shurtleff worldwide president, P.
Laxmin Laxminarain, together the
companies will create “one of the
world’s broadest portfolios and one
of the deepest pipelines in the
neurovascular industry”.The above article was sent to subscribers in Pharmacy Daily's issue from 30 Sep 10 To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 30 Sep 10
THE stark health inequalities between Australians living in regional and metro areas have been highlighted in a new report from The Royal Flying Doctor Service (RFDS).
AN “AI explosion” is sweeping Australia’s healthcare sector, signalling the arrival of an “extraordinary era of medicine”, according to a new report from CSIRO.
THE Australian and New Zealand College of Advanced Pharmacy (ANZCAP) has celebrated the 1,000th pharmacist to complete its pharmacy recognition program (PD 24 Nov 2023).
FREE Pharmacy Daily subscription - never miss another story!
to top
Subscribe to Pharmacy Daily
Pharmacy Daily subscription confirmation
Thank you for signing up! Check your email inbox – you should shortly receive a message with a link which must be clicked to confirm your subscription.
Once you’ve done that you will begin receiving Pharmacy Daily as soon as the next issue is published.